Microbiology is defined as the branch of medical science, which deals with the treatment, diagnosis, and prevention of infectious diseases. Microbiology testing is described as the analysis and diagnostic testing of various products by use of biological, chemical, biochemical, and/or molecular methods for identifying any contaminants or presence of any microorganisms in the product. This involves extracting a sample out of the product and analyzing it under different conditions and through different methods to assist reach conclusive evidence. Microbiology testing is employed for the rapid identification of the microorganism and for the treatment of the infectious diseases caused by bacteria, fungus, viruses, parasites, and other microorganism. Rapid microbiology testing method is referred as microbiological methods. These are the technologies that are useful to induce microbiology tests results faster as compared to traditional culture plate methods.
Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/13944
COVID-19
Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Key
Market Players
- Abbott Laboratories
- Agilent Technologies Inc
- Becton, Dickinson and Company
- Beckman Coulter Inc.
- Biomerieux SA
- BioRad Laboratories Inc.
- Roche, Holding AG
- Hologic
- Danaher Company
- Thermo Fisher Scientific
0 Comments